Label Image (Lbl530025624)
Losartan Potassium
Product Images NDC 53002-5624
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-5624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Losartan Fig1)
This appears to be a graph or chart of some sort, showing the adjusted risk reduction percentages for Atenolol and Losartan Potassium over a period of 66 study months. Due to the lack of additional information, it is not possible to provide more context or details about the study or its findings.*
Figure2 (Losartan Fig2)
Figure 3 (Losartan Fig3)
This appears to be a table or a figure depicting primary endpoint events within different demographic subgroups, showing results for age, gender, race, and other factors. The specific details of the results cannot be determined due to the unclear text.*
Figure-4 (Losartan Fig4)
This is a statistical representation of an event in a study evaluating the effectiveness of Losartan Potassium compared to a placebo. The text indicates that out of the patients involved, 60% had an event in the Losartan group, while 40% had an event in the placebo group. The risk reduction was found to be 16.1% with a p-value of 0.022.*
Chemical Structure (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
